Form 8-K - Current report:
SEC Accession No. 0001493152-24-050801
Filing Date
2024-12-19
Accepted
2024-12-19 17:00:18
Documents
22
Period of Report
2024-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40848
2 ex10-1.htm EX-10.1 9066
3 ex10-1_001.jpg GRAPHIC 59741
4 ex10-1_002.jpg GRAPHIC 297684
5 ex10-1_003.jpg GRAPHIC 223765
6 ex10-1_004.jpg GRAPHIC 234770
7 ex10-1_005.jpg GRAPHIC 312397
8 ex10-1_006.jpg GRAPHIC 275696
9 ex10-1_007.jpg GRAPHIC 247481
10 ex10-1_008.jpg GRAPHIC 101103
  Complete submission text file 0001493152-24-050801.txt   2643378

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE juns-20241215.xsd EX-101.SCH 3051
12 XBRL LABEL FILE juns-20241215_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE juns-20241215_pre.xml EX-101.PRE 24189
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3779
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41265 | Film No.: 241564069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)